4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-046054
COO, CFO sold 4,500 shares at $33.75 ($151,875)
- COO, CFO acquired 4,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kung Winston · COO, CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-08 | Exercise or conversion : show line 1 in the form | +4,500 | $3.22 | $14,490 | 6,100 | D |
| 2021-07-08 | Sale : show line 2 in the form | −4,500 | $33.75 | $151,875 | 1,600 | D |
| Open-market sales · 4,500 sh · avg $33.75 · $151,875 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-08 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −4,500 | 223,534 | D |
Loading xslF345X03/doc4.xml…